Ovation Science Topicals Launch with Planet 13 in Nevada

Vancouver, BC, Las Vegas, NV – April 30, 2024 (CSE: OVAT | OTCQB: OVATF) – Ovation…

Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx™ in…

Pressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”

PBIO Receives Critical Processor License for Industrial Hemp in MA.New License and…

Uncle Bud’s Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.

Uncle Bud’s Reports Early Synergies and Measurable Performance Metrics in First Month…

Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Topline Results Expected in Q2 2024 This is a Designated News Release.…

IGC Pharma Reports Third Quarter Fiscal 2024 Results

POTOMAC, Md., February 17, 2024–(BUSINESS WIRE)–IGC Pharma, Inc. (“IGC” or the “Company”)…

Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Designation Based on Pre-Clinical Data and Initial Clinical Data from the Company’s…